S&P 500   3,441.77 (-0.04%)
DOW   28,264.05 (-0.16%)
QQQ   284.85 (+0.15%)
AAPL   117.26 (-0.21%)
MSFT   213.85 (-0.37%)
FB   279.60 (+4.50%)
GOOGL   1,573.00 (+2.81%)
AMZN   3,216.00 (-0.03%)
TSLA   421.20 (-0.18%)
NVDA   542.11 (-0.68%)
BABA   311.20 (+0.45%)
CGC   19.10 (+1.17%)
GE   7.29 (-0.68%)
MU   53.32 (-0.39%)
AMD   81.62 (+0.07%)
T   26.80 (+0.15%)
F   7.76 (+0.26%)
ACB   4.60 (+0.88%)
GILD   60.35 (-0.36%)
NFLX   503.10 (-4.25%)
BA   166.90 (-0.20%)
BAC   24.24 (+0.41%)
DIS   124.89 (-0.05%)
S&P 500   3,441.77 (-0.04%)
DOW   28,264.05 (-0.16%)
QQQ   284.85 (+0.15%)
AAPL   117.26 (-0.21%)
MSFT   213.85 (-0.37%)
FB   279.60 (+4.50%)
GOOGL   1,573.00 (+2.81%)
AMZN   3,216.00 (-0.03%)
TSLA   421.20 (-0.18%)
NVDA   542.11 (-0.68%)
BABA   311.20 (+0.45%)
CGC   19.10 (+1.17%)
GE   7.29 (-0.68%)
MU   53.32 (-0.39%)
AMD   81.62 (+0.07%)
T   26.80 (+0.15%)
F   7.76 (+0.26%)
ACB   4.60 (+0.88%)
GILD   60.35 (-0.36%)
NFLX   503.10 (-4.25%)
BA   166.90 (-0.20%)
BAC   24.24 (+0.41%)
DIS   124.89 (-0.05%)
S&P 500   3,441.77 (-0.04%)
DOW   28,264.05 (-0.16%)
QQQ   284.85 (+0.15%)
AAPL   117.26 (-0.21%)
MSFT   213.85 (-0.37%)
FB   279.60 (+4.50%)
GOOGL   1,573.00 (+2.81%)
AMZN   3,216.00 (-0.03%)
TSLA   421.20 (-0.18%)
NVDA   542.11 (-0.68%)
BABA   311.20 (+0.45%)
CGC   19.10 (+1.17%)
GE   7.29 (-0.68%)
MU   53.32 (-0.39%)
AMD   81.62 (+0.07%)
T   26.80 (+0.15%)
F   7.76 (+0.26%)
ACB   4.60 (+0.88%)
GILD   60.35 (-0.36%)
NFLX   503.10 (-4.25%)
BA   166.90 (-0.20%)
BAC   24.24 (+0.41%)
DIS   124.89 (-0.05%)
S&P 500   3,441.77 (-0.04%)
DOW   28,264.05 (-0.16%)
QQQ   284.85 (+0.15%)
AAPL   117.26 (-0.21%)
MSFT   213.85 (-0.37%)
FB   279.60 (+4.50%)
GOOGL   1,573.00 (+2.81%)
AMZN   3,216.00 (-0.03%)
TSLA   421.20 (-0.18%)
NVDA   542.11 (-0.68%)
BABA   311.20 (+0.45%)
CGC   19.10 (+1.17%)
GE   7.29 (-0.68%)
MU   53.32 (-0.39%)
AMD   81.62 (+0.07%)
T   26.80 (+0.15%)
F   7.76 (+0.26%)
ACB   4.60 (+0.88%)
GILD   60.35 (-0.36%)
NFLX   503.10 (-4.25%)
BA   166.90 (-0.20%)
BAC   24.24 (+0.41%)
DIS   124.89 (-0.05%)
Log in
NASDAQ:ANIX

Anixa Biosciences Stock Forecast, Price & News

$2.33
-0.01 (-0.43 %)
(As of 10/21/2020 09:15 AM ET)
Add
Compare
Today's Range
$2.33
Now: $2.33
$2.36
50-Day Range N/A
52-Week Range
$1.33
Now: $2.33
$4.24
Volume66 shs
Average Volume244,592 shs
Market Capitalization$55.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.19
Anixa Biosciences, Inc., a biotechnology company, develops diagnostics and therapeutics to diagnose, treat, and prevent cancer. The company is developing the Cchek platform, a series of non-invasive blood tests for the early detection of cancer, which is based on the body's immune response to the presence of a malignancy. It is also developing a vaccine against triple negative breast cancer; and chimeric endocrine receptor T-cell technology focused on treating ovarian cancer. Anixa Biosciences, Inc. has a collaboration with Urology San Antonio, P.A. and Idaho Urologic Institute, PA for the development of Cchek, a liquid biopsy technology; and with OntoChem GmbH to develop novel Covid-19 therapeutics. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ANIX
CUSIPN/A
CIKN/A
Phone408 708 9808
Employees7

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$250,000.00
Book Value$0.24 per share

Profitability

Net Income$-11,650,000.00

Miscellaneous

Market Cap$55.43 million
Next Earnings Date1/14/2021 (Estimated)
OptionableNot Optionable
$2.33
-0.01 (-0.43 %)
(As of 10/21/2020 09:15 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ANIX News and Ratings via Email

Sign-up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Anixa Biosciences (NASDAQ:ANIX) Frequently Asked Questions

When is Anixa Biosciences' next earnings date?

Anixa Biosciences is scheduled to release its next quarterly earnings announcement on Thursday, January 14th 2021.
View our earnings forecast for Anixa Biosciences
.

How were Anixa Biosciences' earnings last quarter?

Anixa Biosciences, Inc. (NASDAQ:ANIX) issued its quarterly earnings results on Tuesday, September, 8th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.01.
View Anixa Biosciences' earnings history
.

Who are some of Anixa Biosciences' key competitors?

What other stocks do shareholders of Anixa Biosciences own?

Who are Anixa Biosciences' key executives?

Anixa Biosciences' management team includes the following people:
  • Dr. Amit Kumar Ph.D., Chairman, Pres & CEO (Age 56, Pay $665.49k)
  • Mr. Michael J. Catelani, COO, CFO & Corp. Sec. (Age 53, Pay $313.02k)
  • Mr. John Roop, Sr. VP of Engineering (Age 70)
  • Mr. Thomas Schlumpberger, Exec. VP of Diagnostics

What is Anixa Biosciences' stock symbol?

Anixa Biosciences trades on the NASDAQ under the ticker symbol "ANIX."

How do I buy shares of Anixa Biosciences?

Shares of ANIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Anixa Biosciences' stock price today?

One share of ANIX stock can currently be purchased for approximately $2.33.

How big of a company is Anixa Biosciences?

Anixa Biosciences has a market capitalization of $55.43 million and generates $250,000.00 in revenue each year. The company earns $-11,650,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Anixa Biosciences employs 7 workers across the globe.

What is Anixa Biosciences' official website?

The official website for Anixa Biosciences is www.anixa.com.

How can I contact Anixa Biosciences?

Anixa Biosciences' mailing address is 3150 ALMADEN EXPRESSWAY SUITE 250, SAN JOSE CA, 95118. The company can be reached via phone at 408 708 9808 or via email at [email protected]

This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.